Nachrichten zur Pfizer Inc. Aktie

Pfizer: Neuer Adipositas-Deal

Der Pharma-Riesen Novo Nordisk und Eli Lilly haben dem wachsenden Markt für Adipositas-Medikamente weiter fest im Griff. Mit Übernahmen brachten…

GSK, Pfizer to appeal Delaware ruling that allowed trials for thousands of Zantac cases

…

Pfizer Inc. (PFE) CEO Albert Bourla presents at Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)

…

Modernas combination Covid, flu vaccine is more effective than existing shots in late-stage trial

Moderna is the first company to release positive phase three data on a Covid and flu combination shot, giving it…

Pfizer: 3 Gründe für die Underperformance der Dividenden-Aktie

Die Aktie des Pharma-Riesen Pfizer läuft seit einigen Quartalen der Peergroup hinterher. Merck & Co ist inzwischen mehr als doppelt…

Pfizer: 3 Gründe für die Underperformance der Dividenden-Aktie

Die Aktie des Pharma-Riesen Pfizer läuft seit einigen Quartalen der Peergroup hinterher. Merck & Co ist inzwischen mehr als doppelt…

Want $1,000 in Dividend Income? Heres How Much Youd Have to Invest in Pfizer Stock.

Pfizer is a cheap buy with a mouthwatering yield.…

FDA approves GSKs RSV vaccine for high-risk adults ages 50 to 59, expanding shots reach

The FDAs expanded approval could help GSK maintain its dominance in the RSV market, which includes shots from Pfizer and…

Thinking Of Buying Pfizer For Its 5.8% Dividend Yield? Consider This Alternative Option Instead

…

Pfizer: Surging Cancer Rates Will Boost Revenues

…

Pfizer: Too Early For A Turnaround

…

Pfizer: Too Cheap To Miss Out

…

Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel

An FDA panel recommended that Moderna, Pfizer-BioNTech, and Novavax should develop new Covid-19 vaccines that target the JN.1 variant of…

FDA Panel Recommends New COVID Vaccines For JN.1 Lineage By Fall

Drug manufactures Moderna, Pfizer and Novavax said they expect the new vaccines will be available this fall in time for…

Why Things Could Get Worse for Pfizer Stock Before They Get Better @themotleyfool #stocks $PFE

Investors shouldnt expect a big improvement in Pfizers financials this year.…

Why Things Could Get Worse for Pfizer Stock Before They Get Better

Investors shouldnt expect a big improvement in Pfizers financials this year.…

1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer @themotleyfool #stocks $PFE

Pfizers list of patent-protected medicines is growing by leaps and bounds, but its stock price is under pressure.…

1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer

Pfizers list of patent-protected medicines is growing by leaps and bounds, but its stock price is under pressure.…

Märkte am Morgen: Anleger warten EZB und Jobdaten ab; Silber, Nvidia, Pfizer, Deutsche Telekom, Hannover Rück, Nemetschek, DWS, TUI im Fokus

Der immer näher rückende Zinsentscheid der Europäischen Zentralbank (EZB) am Donnerstag hält den deutschen Aktienmarkt im Bann. Nach dem freundlichen…

Hims & Hers Health Soars on Generic GLP-1 Rollout Plans

Him & Hers Health Inc. (NYSE: HIMS) provides a direct-to-consumer (DTC) health and wellness platform. The company was best known…

Pfizer, Sanofi und Co: Gerichtsschock – Aktien unter Druck

Dieses Gerichtsverfahren droht Pfizer, Sanofi und GSK.…

GSK, Pfizer und Sanofi unter Druck: Zantac-Klagen könnten Milliarden kosten

Gleich mehrere große Pharmakonzerne müssen sich wegen möglicher Krebsrisiken des Medikaments Zantac in den USA vor Gericht verantworten. Etwa 75.000…

Asiens Börsen uneinheitlich -- OPEC+ setzt Angebots-Drosselung fort -- Pfizer, GSK, Sanofi & Co.: Pharmakonzerne mit Zantac-Klagen vor Gericht konfrontiert -- Thales im Fokus

Der deutsche Aktienmarkt zeigte sich am Freitag unentschlossen.Der DAX stand zur Eröffnung bereits nahe der Nulllinie und wechselte daraufhin …

"Dividende ist unantastbar": Günstige Dividendenperle Pfizer: Sicherheit in unsicheren Zeiten

GSK, Pfizer must face tens of thousands of Zantac cases in Delaware

…

"Dividende ist unantastbar": Eine hochsichere und günstige Dividendenaktie für stürmische Zeiten

Is Pfizer the Best Dividend Stock for You?

Short-term expectation worries have elevated Pfizers dividend yield.…

Pfizer posts long-term data to support lung cancer therapy Lorbrena

…

Pfizers drug for advanced lung cancer shows promising long-term trial results

The companys medicine helped patients live longer without seeing their cancer progress, as most of them experienced that benefit for…

Moderna und BioNTech-Partner Pfizer stark: Kampf gegen Vogelgrippe - Millionenförderung in ...

Die Aktie von Moderna hat am Donnerstag neuen Schwung erhalten. Moderna konnte an einem insgesamt schwachen Handelstag 2,4 Prozent zulegen…

Moderna und BioNTech-Partner Pfizer stark: Kampf gegen Vogelgrippe – Millionenförderung in Sicht

Die Aktie von Moderna hat am Donnerstag neuen Schwung erhalten. Moderna konnte an einem insgesamt schwachen Handelstag 2,4 Prozent zulegen…

Is Pfizer an Excellent Dividend Stock to Buy for Passive Income Investors?

Pfizers dividend yield is rising as the stock price is falling.…

Is Pfizer an Excellent Dividend Stock to Buy for Passive Income Investors?

…

Global Dyspepsia Drugs Market Size To Worth Exceed USD 14.7 Billion By 2033 | CAGR Of 4.46%

The Global Dyspepsia Drugs Market Size was Valued at USD 9.5 Billion in 2023 and the Worldwide Dyspepsia Drugs Market…

5 Biggest Pharmaceutical ETFs in 2024

The global pharmaceutical market reached a total value of US$1.6 trillion in 2023, according to Statista, up significantly from the…

Pfizer: The Chart Looks Like A Bottom, But Is The Dividend Safe?

…

Pfizer: Turning The Corner (Rating Upgrade)

…

How Much Will Pfizer Pay Out in Dividends This Year?

As one of the worlds largest drugmakers, Pfizer generates lots of cash it can share with investors.…

Global Topical Wound Agents Market Size To Exceed USD 3.7 Billion By 2033 | CAGR Of 6.89%

The Global Topical Wound Agents Market Size was valued at USD 1.9 Billion in 2023 and the Global Topical Wound…

Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032

PALM BEACH, Fla., May 24, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The pancreatic cancer…

Pfizer: Down To A Historically Low Valuation - Is It A Buy?

…

Global Systemic Aspergillosis and Systemic Candidiasis Research Report 2024-2030 Featuring Sanofi, Cipla, Pfizer, GSK, Novartis, Bayer, Merck, F. Hoffmann-La Roche, Abbott, Gilead Sciences

Dublin, May 24, 2024 (GLOBE NEWSWIRE) -- The "Global Systemic Aspergillosis and Systemic Candidiasis Market (2024 Edition): Analysis…

dpa-AFX ProFeed